IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars

Brands

Yourlist
Quizie
FaithTap
Blessed
All brands

Apollo Eyes $20 Billion J&J Orthopedics Unit — Sep 11, 2026Apollo Global Management is poised to acquire Johnson & Johnson's DePuy Synthes orthopedics unit for about $20 billion, a deal that would value the asset at roughly two times its sales as J&J considers a tax-free spin-off or other paths to sharpen focus on higher-growth healthcare areas. DePuy Synthes generated about $9.3 billion in 2025 revenue but trails faster-growing segments and carries thousands of hip-implant lawsuits that would influence buyer pricing.

Marcus Bell Two times sales feels fair given the revenue but the lawsuits could still force a lower final price.

Johnson & Johnson Acquires V-Wave For $1.7 Billion To Boost Heart Failure Treatment Portfolio‌ ‌ — Aug 27, 2024Global healthcare giant Johnson & Johnson (J&J) announced on Tuesday that it will acquire Israeli startup V-Wave for up to $1.7 billion, in a strategic move by J&J to bolster its position in the fast-growing congestive…

Johnson & Johnson Folds to Pushback on Lifesaving DrugReporting — Jul 17, 2023Drug manufacturer Johnson & Johnson (J&J) agreed to remove some of its control over generic multidrug-resistant tuberculosis (MDR-TB) medication after being criticized for “trying to immorally extend their patent.”…

J&J Scientists Refute Idea That COVID-19 Vaccine’s Design Linked To ClotsReporting — Apr 17, 2021Scientists at Johnson & Johnson on Friday refuted an assertion in a major medical journal that the design of their COVID-19 vaccine, which is similar AstraZeneca’s, may explain why both have been linked to very rare…

IJREXCLUSIVE: Trump’s EPA Wants More Plastic Turned Into New Products, And The Paper Lobby Is Fighting ItSimon August · 4 min · 2h

White House Says It Is Working To Speed Early Production of J&J COVID-19 VaccineReporting — Feb 6, 2021The Biden administration is exploring every option for increasing manufacturing of Johnson & Johnson’s COVID-19 vaccine, which is under regulatory review, and said on Friday that currently expected levels of early doses…

YourlistRankingMost Influential Women in World HistoryFrom ancient queens who ruled empires to modern activists who changed laws, these women left indelible marks on politics, science, and culture. Vote for who you think shaped history most profoundly.1379 votes · 26 candidates

Fauci Says He Believes J&J Vaccine Will ‘Get Back on Track Soon’Reporting — Apr 15, 2021Anthony Fauci, the top U.S. infectious disease doctor, hopes U.S. regulators will make a quick decision to lift a pause on the Johnson & Johnson vaccine and get that vaccine “back on track,” he said in an interview with…

J&J COVID-19 Vaccine ‘Pause’ Reviewed, U.S. Officials Hope To Resume ShotsReporting — Apr 23, 2021Advisers to the U.S. Centers for Disease Control and Prevention will meet again on Friday to consider whether to it is safe to resume injections of Johnson & Johnson’s COVID-19 vaccine, as senior U.S. health officials…

Doctors Say Clot Treatment Advice Key To US Resuming J&J COVID VaccinesReporting — Apr 19, 2021Resuming the use of Johnson & Johnson’s COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as…

J&J COVID-19 Vaccine Is 66 Percent Effective GloballyReporting — Jan 29, 2021Johnson & Johnson on Friday said its single-dose vaccine was 72% effective in preventing COVID-19 in the United States but a lower rate of 66% was observed globally in the large trial conducted across three continents…

On X · @hudsonwupdatesFan Account Shares Hudson Williams’ Instagram Celebration of First TIFF AppearanceFan-driven post highlighting Hudson Williams' successful TIFF panel and appearances receives overwhelmingly positive support from dedicated fandom accounts, with enthusiastic reactions and no visible opposition in sampled replies.402 likes · 17m

US Pauses J&J COVID-19 Vaccine Over Rare Blood ClotsReporting — Apr 13, 2021U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women under 50 who had received it developed rare blood clots, dealing a fresh setback to efforts to…

Third US COVID-19 Vaccine By J&J Available in 1-2 Days: CEOReporting — Mar 1, 2021Americans should be able to receive Johnson & Johnson’s COVID-19 vaccine within the next 24 to 48 hours, its chief executive said on Monday after U.S. regulators approved the vaccine, making it the country’s third…

YourlistVS BattleMadonna vs Lady GagaThe Queen of Pop versus the artist who studied at her throne.Madonna vs Lady Gaga · 152 votes — pick a side

US Advisory Panel Wants More Data Before Ending Pause on J&J COVID-19 VaccineReporting — Apr 14, 2021A U.S. health panel on Wednesday agreed they wanted more data before voting to resume vaccinations with Johnson & Johnson’s COVID-19 shot, even as a U.S. Food and Drug Administration scientist said warnings could…

Fauci Says Pause on J&J COVID-19 Shot Should Not Prompt Vaccine HesitancyReporting — Apr 15, 2021Top U.S. health officials urged Americans to get vaccinated against COVID-19 on Wednesday, saying U.S. regulators’ pause on Johnson & Johnson shots, following reports it can cause blood clotting, should boost confidence…

J&J COVID-19 Vaccine Shipping to US, but New Deliveries Hinge on RegulatorsReporting — Mar 1, 2021Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is…

DDaily Caller News FoundationEXCLUSIVE: Trump’s EPA Wants More Plastic Turned Into New Products, And The Paper Lobby Is Fighting ItA conservative group is pressing six paper giants to rein in their lobbying against a Trump administration-backed push to recycle more plastic.2h

Peeling Paint, Unsanitary Practices Among Issues at US Plant Making J&J COVID-19 Vaccine: FDAReporting — Apr 21, 2021A U.S. plant that was making Johnson & Johnson’s COVID-19 vaccine must fix a long list of problems including peeling paint and unsanitary conditions and practices to resume operation, according to a highly critical…

QuizieQuizHow charismatic are you, really?Not a score out of ten — the AI identifies your specific brand of charm and where it's most dangerous.3 min · today's quiz

J&J Wins FDA De Novo OTTAVA System — Jul 22, 2026Johnson & Johnson has received FDA De Novo clearance for its Ottava robotic surgical system, marking its entry into the U.S. market as a table-integrated, space-saving alternative aimed at general soft-tissue procedures. The company plans a selective U.S. rollout and ongoing global expansion, supported by an inguinal hernia trial and continued development of additional indications and regulatory approvals amid competition from Intuitive Surgical's established da Vinci platform.